Purpose: Pharmacogenetic testing can inform drug dosing and selection by aiding in estimating a patient's genetic risk of adverse response and/or failure to respond. Some pharmacogenetic tests may ...
Pharmacogenetics is the study of the contribution of genes and gene variants to inter-individual variation in drug response. 1 Although the study of genetic determinants of drug response began more ...
Please provide your email address to receive an email when new articles are posted on . Retina specialists have a series of ancillary testing modalities at their disposal. But data on how often ...
In recent years, small volume biopsies have been increasingly utilized for diagnosis of tumors in both primary and recurrent settings. Concomitantly, the numbers of ancillary studies for ...
<0> Research and Markets: Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Supplier Shares and Sales Forecasts for 300 Tests </0> <0> Research and MarketsLaura Wood, Senior ManagerU.S ...
Factors associated with BRCA 1/2 testing among young women from hereditary breast and ovarian cancer families. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does ...
NEW YORK, Dec. 10, 2018 /PRNewswire/ -- 2019-2023 Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results